Home
About us
Ventures
Team
Newsroom
Contact
Investor Relations
Deutsch
Home
About us
Ventures
Team
Newsroom
Contact
Investor Relations
Deutsch
Investor Relations
NEWSROOM
Overview of the latest Company News, Press Releases and Ad-hoc announcements
Featured
SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5), the European group of companies specialising in medical cannabis and industrial hemp, is launching...
Read more
Recent
Articles Corporate News
More Corporate News
IRIS Capital invests in SYNBIOTIC's growth strategy
SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin
Recent
Press Reviews
More Press Reviews
1,6 Millionen Euro für Hanf Farm: Bundesministerium für Wirtschaft und Klimaschutz fördert Bio-Ökonomie-Projekt
SynBiotic: neue Pflichtwandelanleihe in petto
Welche ökonomischen Chancen das neue Cannabis-Gesetz bietet
Recent
Ad-hoc Releases
More Ad-hoc Releases
SYNBIOTIC SE geht mit der GOC NEXUS OPERATIONS GMBH strategische Partnerschaft ein.
SYNBIOTIC SE: Einbringung der CannaCare Health GmbH wird nicht durchgeführt.
SynBiotic SE schließt Einbringungsvertrag über den Erwerb von 50,2 % der Anteile an der greensby UG (haftungsbeschränkt), Vettweiss, ab.
